Big Move For Vaxart, Inc.

Tue, Feb 02, 2021 at 05:30 PM

Vaxart, Inc. (VXRT:NASDAQ) soared at $23.33, representing a gain of 49.8%. On Mon 01 Feb 21, VXRT:NASDAQ hit a New 2-Week High of $15.57. The stock appeared on our News Catalysts scanner on Tue 02 Feb 21 at 08:22 AM in the 'BIOTECH' category. From Tue 19 Jan 21, the stock recorded 55.56% Up Days and 60.00% Green Days

About Vaxart, Inc. (VXRT:NASDAQ)

Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.

Top 10 Gainers:

Cassava Sciences, Inc. (SAVA:NASDAQ), 141.15%
Ocugen, Inc. (OCGN:NASDAQ), 80.11%
HOL (HOL:NASDAQ), 57.09%
Vaxart, Inc. (VXRT:NASDAQ), 49.84%
Aeterna Zentaris Inc. (AEZS:NASDAQ), 42.86%
Lizhi Inc. (LIZI:NASDAQ), 41.37%
NTN Buzztime, Inc. (NTN:NYSEMKT), 36.91%
Moleculin Biotech, Inc. (MBRX:NASDAQ), 35.96%
SELLAS Life Sciences Group, Inc. (SLS:NASDAQ), 34.1%
The9 Limited (NCTY:NASDAQ), 33.09%